The objective of ongoing investigations on the PI3K/AKT/PTEN signalling system in polycystic ovary syndrome (PCOS) is to ascertain the viability of a pharmacological intervention capable of effectively addressing ovarian dysfunction30. This evidence concerns the gene PTEN and polycystic ovary syndrome.